Literature DB >> 19386270

Inhibition of endothelial cell apoptosis by netrin-1 during angiogenesis.

Marie Castets1, Marie-May Coissieux, Céline Delloye-Bourgeois, Laure Bernard, Jean-Guy Delcros, Agnès Bernet, Vincent Laudet, Patrick Mehlen.   

Abstract

Netrin-1 was recently proposed to play an important role in embryonic and pathological angiogenesis. However, data reported led to the apparently contradictory conclusions that netrin-1 is either a pro- or an antiangiogenic factor. Here, we reconcile these opposing observations by demonstrating that netrin-1 acts as a survival factor for endothelial cells, blocking the proapoptotic effect of the dependence receptor UNC5B and its downstream death signaling effector, the serine/threonine kinase DAPK. The netrin-1 effect on blood vessel development is mimicked by caspase inhibitors in ex vivo assays, and the inhibition of caspase activity, the silencing of the UNC5B receptor, and the silencing of DAPK are each sufficient to rescue the vascular sprouting defects induced by netrin-1 silencing in zebrafish. Thus, the proapoptotic effect of unbound UNC5B and the survival effect of netrin-1 on endothelial cells finely tune the angiogenic process.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19386270     DOI: 10.1016/j.devcel.2009.02.006

Source DB:  PubMed          Journal:  Dev Cell        ISSN: 1534-5807            Impact factor:   12.270


  58 in total

1.  Cytoprotective and proangiogenic activity of ex-vivo netrin-1 transgene overexpression protects the heart against ischemia/reperfusion injury.

Authors:  Shazia Durrani; Khawaja Husnain Haider; Rafeeq P H Ahmed; Shujia Jiang; Muhammad Ashraf
Journal:  Stem Cells Dev       Date:  2011-11-11       Impact factor: 3.272

Review 2.  Cell-matrix interactions in mammary gland development and breast cancer.

Authors:  John Muschler; Charles H Streuli
Journal:  Cold Spring Harb Perspect Biol       Date:  2010-08-11       Impact factor: 10.005

Review 3.  Axon guidance molecules in vascular patterning.

Authors:  Ralf H Adams; Anne Eichmann
Journal:  Cold Spring Harb Perspect Biol       Date:  2010-03-31       Impact factor: 10.005

4.  CD146: the unveiling of a pro-angiogenic netrin receptor.

Authors:  Brad St Croix
Journal:  Cell Res       Date:  2015-04-07       Impact factor: 25.617

5.  AAV-mediated netrin-1 overexpression increases peri-infarct blood vessel density and improves motor function recovery after experimental stroke.

Authors:  Hui Sun; Thang Le; Tiffany T J Chang; Aisha Habib; Steven Wu; Fanxia Shen; William L Young; Hua Su; Jialing Liu
Journal:  Neurobiol Dis       Date:  2011-06-25       Impact factor: 5.996

6.  The bipartite rac1 Guanine nucleotide exchange factor engulfment and cell motility 1/dedicator of cytokinesis 180 (elmo1/dock180) protects endothelial cells from apoptosis in blood vessel development.

Authors:  Kathrin Schäker; Susanne Bartsch; Christian Patry; Sandra J Stoll; Jan-Luuk Hillebrands; Thomas Wieland; Jens Kroll
Journal:  J Biol Chem       Date:  2015-01-13       Impact factor: 5.157

7.  The Cullin 3 substrate adaptor KLHL20 mediates DAPK ubiquitination to control interferon responses.

Authors:  Yu-Ru Lee; Wei-Chien Yuan; Hsuan-Chung Ho; Chun-Hau Chen; Hsiu-Ming Shih; Ruey-Hwa Chen
Journal:  EMBO J       Date:  2010-04-13       Impact factor: 11.598

8.  Evaluation of the colorectal cancer risk conferred by rare UNC5C alleles.

Authors:  Sébastien Küry; Céline Garrec; Fabrice Airaud; Flora Breheret; Virginie Guibert; Cécile Frenard; Shuo Jiao; Dominique Bonneau; Pascaline Berthet; Céline Bossard; Olivier Ingster; Estelle Cauchin; Stéphane Bezieau
Journal:  World J Gastroenterol       Date:  2014-01-07       Impact factor: 5.742

Review 9.  Netrin ligands and receptors: lessons from neurons to the endothelium.

Authors:  Frederic Larrieu-Lahargue; Kirk R Thomas; Dean Y Li
Journal:  Trends Cardiovasc Med       Date:  2012-07-28       Impact factor: 6.677

10.  PKCα is involved in the progression of kidney carcinoma through regulating netrin-1/UNC5B signaling pathway.

Authors:  Bo Zhan; Chuize Kong; Kunfeng Guo; Zhe Zhang
Journal:  Tumour Biol       Date:  2013-03-23
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.